• I-Mab Expands Next-Gen Novel Oncology Portfolio contractpharma
    July 12, 2021
    I-Mab, a clinical stage biopharmaceutical company developing novel biologics, signed two new collaborations with Immorna, an mRNA biotech company, and neoX Biotech, an AI-enabled R&D biotech company.
PharmaSources Customer Service